Don’t let the high cost of brand ICS/LABA inhaler disrupt your asthma/COPD care. We help eligible patients access Wixela Inhub (fluticasone/salmeterol) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Wixela PAP — already generic.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$280 | Save modestly |
| CVS Pharmacy | ~$300 | Save modestly |
| Walmart | ~$170 | Save modestly |
| Costco | ~$160 | Save modestly |
Semglee glargine (alt) | ~$170 | Alt ICS/LABA |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Wixela already generic — substantially cheaper than brand Advair. Other ICS/LABA generics (Breyna for Symbicort) also affordable.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Wixela Inhub:
Still $150–$300 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Wixela Inhub assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Wixela Inhub is generic Advair Diskus — same active drugs (fluticasone propionate ICS + salmeterol LABA) in same Diskus dry-powder device. FDA-approved bioequivalent. Substantially cheaper than brand Advair.
How Wixela Inhub Works:
Inhaled corticosteroid (ICS) reduces airway inflammation. Long-acting beta-agonist (LABA) provides 12-hour bronchodilation. Combined ICS/LABA standard maintenance for asthma and many COPD patients.
Wixela Inhub same drug delivery as Advair Diskus — both use Diskus dry-powder device design.
Form and use:
Wixela Inhub 1 inhalation BID. Three strengths (100/50, 250/50, 500/50 — fluticasone/salmeterol mcg).
Generic availability:
Wixela Inhub is the generic. Other ICS/LABA: Breyna (budesonide/formoterol — Symbicort generic, also generic), Airduo Digihaler/Respiclick (fluticasone/salmeterol — different device), Breo Ellipta (fluticasone furoate/vilanterol — brand once-daily), Dulera (mometasone/formoterol — brand).
Warnings:
LABA class warning for asthma — must always combine with ICS in asthma. Oral candidiasis (rinse mouth), pneumonia risk in COPD (small), HPA suppression with high doses, dysphonia, paradoxical bronchospasm.
Wixela $150–$300/inhaler — already generic of Advair. Brand Advair Diskus $400+.
Yes — FDA-approved generic equivalent. Same drug, same device, much cheaper.
Both FDA-approved. For asthma, ICS/LABA standard step-up therapy. For COPD, ICS/LABA for frequent exacerbators (often as part of triple therapy now).
Wixela already generic. Other ICS/LABA generics available.
Wixela Inhub already generic Advair — substantially cheaper than brand. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.